Immunochemotherapy for malignant tumors, particularly...

Details Immunochemotherapy for malignant tumors, particularly... Immunochemotherapy for malignant tumors, particularly...

A - Human Necessities

61

K

167/129

A61K 39/00 (2006.01) A61K 39/44 (2006.01) A61K 47/48 (2006.01)

Patent

CA 1222694

ABSTRACT OF THE DISCLOSURE An immunochemotherapy process and composition, effective against malignant tumors. The composition is charac- terized by a water soluble, intermediate carrier, to which arsanilic acid, a cytotoxic agent containing an amine group, and specific antibodies are both linked, without being linked or bonded to each other. The composition is water soluble, and the antibodies freely transport the cytotoxic amine-containing agent to the target tumor site where the cytotoxic amine- containing agent kills the tumor. - 2 -

434358

Affiliated with

Also associated with

Rating

Immunochemotherapy for malignant tumors, particularly... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunochemotherapy for malignant tumors, particularly..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunochemotherapy for malignant tumors, particularly... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1293100